Literature DB >> 34228274

Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish.

Derya Cansız1, İsmail Ünal2, Ünsal Veli Üstündağ3, Ahmet Ata Alturfan1, Meriç A Altinoz4, İlhan Elmacı5, Ebru Emekli-Alturfan6.   

Abstract

BACKGROUND: Dysfunction of the gastrointestinal tract (GIT) is one of the most common non-motor symptom of Parkinson's Disease (PD). Pathological processes causing PD were suggested to initiate in the enteric nervous system (ENS) and proceed to the central nervous system (CNS). There are studies showing that low-carbohydrate ketogenic diets can improve motor symptoms of PD. Caprylic acid (C8) is the principal fatty acid component of the medium-chain triglycerides in the ketogenic diets. In this study, we aimed to evaluate the effects of caprylic acid, in neurotoxin exposed zebrafish focusing on the relationship between intestinal and brain oxidative stress and inflammation.
METHODS: Adult zebrafish were exposed to rotenone (5 μg/L) (R group) and caprylic acid (20 and 60 mg/mL) (L + HDCA and R + HDCA groups) for 30 days. At the end of 30 days locomotor activities were determined. Levels of lipid peroxidation (LPO), nitric oxide, glutathione and superoxide dismutase and glutathione S-transferase activities were determined by spectrophotometric methods and gene expressions of tnf⍺, il1, il6, il21, ifnɣ and bdnf were evaluated by RT-PCR in the brain and intestinal tissues of zebrafish.
RESULTS: Caprylic acid ameliorated LPO, NO, SOD and the expressions of tnf⍺, il1, il6, il21, ifnɣ and bdnf in brain and intestines. Locomotor activities were only ameliorated in high dose R + HDCA group.
CONCLUSIONS: Caprylic acid ameliorated the neurotoxin-induced oxidative stress and inflammation both in the brain and intestines and enhanced locomotor activity in zebrafish.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Caprylic acid; Parkinson’s Disease; Rotenone; Zebrafish

Mesh:

Substances:

Year:  2021        PMID: 34228274     DOI: 10.1007/s11033-021-06532-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  49 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 2.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

Review 3.  Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.

Authors:  Hugo González; Francisco Contreras; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-28       Impact factor: 4.147

Review 4.  Levodopa unresponsive symptoms in Parkinson disease.

Authors:  Kapil Sethi
Journal:  Mov Disord       Date:  2008       Impact factor: 10.338

5.  Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios.

Authors:  Richard J Wurtman; Judith J Wurtman; Meredith M Regan; Janine M McDermott; Rita H Tsay; Jeff J Breu
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045

Review 6.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

Review 7.  Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis.

Authors:  Jana Harsanyiova; Tomas Buday; Alzbeta Kralova Trancikova
Journal:  Front Neurosci       Date:  2020-06-17       Impact factor: 4.677

8.  Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.

Authors:  Matthew C L Phillips; Deborah K J Murtagh; Linda J Gilbertson; Fredrik J S Asztely; Christopher D P Lynch
Journal:  Mov Disord       Date:  2018-08-11       Impact factor: 10.338

Review 9.  Gut Inflammation in Association With Pathogenesis of Parkinson's Disease.

Authors:  Qian-Qian Chen; Caroline Haikal; Wen Li; Jia-Yi Li
Journal:  Front Mol Neurosci       Date:  2019-09-13       Impact factor: 5.639

Review 10.  A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.

Authors:  Dong Seok Kim; Ho-Il Choi; Yun Wang; Yu Luo; Barry J Hoffer; Nigel H Greig
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

View more
  2 in total

1.  Octanoate Alleviates Dietary Soybean Oil-Induced Intestinal Physical Barrier Damage, Oxidative Stress, Inflammatory Response and Microbial Dysbiosis in Large Yellow Croaker (Larimichthys Crocea).

Authors:  Zhou Zhang; Yuhang Tang; Wei Fang; Kun Cui; Dan Xu; Guobin Liu; Shuyan Chi; Beiping Tan; Kangsen Mai; Qinghui Ai
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Assessing Anti-Social and Aggressive Behavior in a Zebrafish (Danio rerio) Model of Parkinson's Disease Chronically Exposed to Rotenone.

Authors:  Ovidiu-Dumitru Ilie; Raluca Duta; Roxana Jijie; Ilinca-Bianca Nita; Mircea Nicoara; Caterina Faggio; Romeo Dobrin; Ioannis Mavroudis; Alin Ciobica; Bogdan Doroftei
Journal:  Brain Sci       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.